Upstream Bio, Inc. (UPB) Balance Sheet
As of 2026-06-30 (10-Q), Upstream Bio, Inc. (UPB) reported total assets of $281.2M, total liabilities of $10.2M and shareholders' equity of $271.0M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $79.4M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
UPBUpstream Bio, Inc.Follow UPB — free
—
Price chart with a free account
- Market cap
- 150.1M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 5 Nov, in 12 days
| Line | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|
| Cash and equivalents | 325.9 | 101.6 | 79.4 | |
| Short-term investments | 144.6 | 239.9 | 181.9 | |
| Receivables | 0.6 | 0.7 | 0.8 | |
| Current assets | 479.2 | 351.8 | 279.6 | |
| Total assets | 481.7 | 353.8 | 281.2 | |
| Current liabilities | 10.7 | 13.5 | 10.0 | |
| Total liabilities | 11.9 | 14.0 | 10.2 | |
| Shareholders' equity | 469.9 | 339.8 | 271.0 |
USD millions · SEC XBRL
Upstream Bio, Inc. — questions
- How much cash does Upstream Bio, Inc. have?
- $79.4M in cash and cash equivalents as of 2026-06-30.
- What are Upstream Bio, Inc.'s total assets?
- $281.2M as of 2026-06-30.
- What is Upstream Bio, Inc.'s shareholders' equity?
- $271.0M as of 2026-06-30.
Every figure on this page comes from Upstream Bio, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.